Replies to post #34049 on Medizone Intl. (fka MZEIQ)

[asepticUNsure]

First and foremost, if the response from Ed Marshall about Canadian struggles had to be extracted by you as a shareholder, via an email as you say, shame on the company for not updating it's investors about progress or lack thereof.

Secondly, I think I had to read and re-read the post about Mr. Esposito. I guess my first assumption, when I read the initial press release was that Esposito would be an active employee, engaging his full attention to fostering MZEI. When I re-read it, if he is merely a "board member", what in the world is that going to accomplish? Who is actually the "boots on the ground", trying to sell this product? Most BOD I know, also sit on the BOD for various other companies simultaneously, which translates into "Esposito is not dedicating 100 percent of his time to MZEI. He is simply there as most BOD to "advise". To make mention below that announcing Esposito is a "commercial turning point", how can electing a BOD member be a commercial move? A commercial move would relate to sales strategy execution, announcement of product acceptance, etc. etc.

Furthermore, if MZEI team thinks Canadian healthcare has struggles right now, and is impeding sales...what in the world should we think is going to happen in the US? There is not one hospital administrator that has there mind on ANYTHING except for the financial impact of obamacare on their bottomline. Even if EPA gave approval tomorrow for aseptic sure, do you think these hospital administrators would start immediately cutting purchase orders for units? I think not. Hospital administrators focus for the entire next 12 months or more will be on the affects of legislation and potential impact to their bottomline. Period. What does that mean for MZEI? It means more time to pass by, more bleeding cash that they don't have, and another round of "we need more money". Which brings up a whole other subject, where is our funding derived from? Do we still have access to the $10mm line which we have not heard a peep about for years?

Our only inkling of light, would be for someone to buy the intellectual property. Any high powered company with acquisition savvy, would look at our SEC filings and know they could make a lowball offer to obtain the patent. Companies that command good buyout prices, command EBITDA multiples. We don't even have an EBIDTA.

[goforthebet]

sign that. thanks for the post

[held2long]

But you never answered NSD's follow-up to that post.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=97103413


Your post sheds some light on half of the problem in Canada.

However, Marshall failed to address the fact that C3 has not announced a single service contract in nearly 2 years of trying. The problems Medizone faces in the healthcare environment do not exist in the private markets C3 was supposedly targeting.

Their original plans were to have service trucks all over Canada by now. What went wrong?

Ben, maybe you can get Marshall to offer an explanation for this situation also.

[Tane61]

EDWIN G. MARSHALL LACKS CREDIBILITY...

With the below statement claiming sales, posted on the company website, being TOTALLY UNTRUE what credence should one afford ANY ALLEGED email from Marshall, let alone ONE attempting to explain away the SOFT LAUNCH FIASCO?

-----

TO DATE, NOT ONE(1) SALE TO A HOSPITAL NOR ONE(1) HOSPITAL SERVICE CONTRACT HAS BEEN REPORTED

Is the below REALITY STATEMENT from Bob Simpson more credible than the rhetoric (and worse) served up by Edwin G. Marshall?


Bob Simpson: (Founding Director at C3)"...very very skeptical and slow.

"It's been presented to a number of people in hospitals, infection control departments etc and they think the technology is fantastic but trying to get a hospital to change its protocol that they have been working with for so long is very difficult. So we have some rather tepid reviews from the hospitals."

----------

TOTALLY UNTRUE STATEMENT!

(This TOTALLY UNTRUE STATEMENT was posted around the time that SMTC was cutting Medizone loose due to issues surrounding unacceptable CREDIT RISK)


"Commencement of commercial deliveries began in April of 2012"


"Initial Sales of AsepticSure™

"Commencement of commercial deliveries began in April of 2012"


The version above was subsequently changed, some months later, to the version below:


"Initial Sales of AsepticSure™

"Commencement of commercial deliveries began in September 2012"

-----

SMTC CORPORATION:

http://www.smtc.com/en/investorrelations/financials/default.aspx (Live Webcast)

SMTC's CEO Discusses Q3 2012 Results - Earnings Call Transcript EXCERPT

Claude Germain - Co-President, Co-Chief Executive Officer, Director

"Let me just jump in, with two quick points, I wanted to close on what you mentioned about Medizone as well.

So there are probably two things, one is at a broader level, always remember that credit is the biggest risk that our company has and our credit policy tends to be very, very tough.

So if we find that a customer for whatever reason is exhibiting a balance sheet which doesn't make us comfortable and if we recall the previous question on inventory, our customers are contractually obligated to take that inventory but to qualify there is, you know, they have to be credit worthy and so that is our biggest risk and so again we tend to be very tough on credit policy and as a result sometimes that can break a relationship and that's something we’re very conscious of but it's something we’re not willing to trade off. In other words we’re not willing to trade off having higher growth rates with looser credit policies.

[never-say-die]

Ben, my post was not meant to be ornery and I can't help it if is depressive because all I do is lay out the facts. Everyone appreciates that you share the tidbits Marshall shares with you, however the selective explanations Marshall offers are not convincing.

Given, sales to Canadian hospitals are tangled up with government in Canada. However, except for the one hospital controlled by Medizone executives, it doesn't explain how there have been no other Canadian trials, no emergency servicing of outbreaks in other hospitals, not even one machine out on trial.

It hasn't even been reported that Zoutmans hospital bought the unit after the outbrerak or even committed to an ongoing service contract.

Then there is C3. Two years and zero sales or service contracts reported to vets, nursing homes, schools, sports facilities clean room applications, just to name a few of their targeted markets.

It's clear ASure is not being accepted in the marketplace on any front.

Why?

No one is saying, they are simply ignoring the situation.